93 related articles for article (PubMed ID: 21316962)
1. Discovery of potent and orally bioavailable heterocycle-based cannabinoid CB1 receptor agonists.
Kiyoi T; Adam JM; Clark JK; Davies K; Easson AM; Edwards D; Feilden H; Fields R; Francis S; Jeremiah F; McArthur D; Morrison AJ; Prosser A; Ratcliffe PD; Schulz J; Wishart G; Baker J; Campbell R; Cottney JE; Deehan M; Epemolu O; Evans L
Bioorg Med Chem Lett; 2011 Mar; 21(6):1748-53. PubMed ID: 21316962
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and structure-activity relationships of indole-3-heterocycles as agonists of the CB1 receptor.
Morrison AJ; Adam JM; Baker JA; Campbell RA; Clark JK; Cottney JE; Deehan M; Easson AM; Fields R; Francis S; Jeremiah F; Keddie N; Kiyoi T; McArthur DR; Meyer K; Ratcliffe PD; Schulz J; Wishart G; Yoshiizumi K
Bioorg Med Chem Lett; 2011 Jan; 21(1):506-9. PubMed ID: 21075630
[TBL] [Abstract][Full Text] [Related]
3. Biarylpyrazolyl oxadiazole as potent, selective, orally bioavailable cannabinoid-1 receptor antagonists for the treatment of obesity.
Lee SH; Seo HJ; Lee SH; Jung ME; Park JH; Park HJ; Yoo J; Yun H; Na J; Kang SY; Song KS; Kim MA; Chang CH; Kim J; Lee J
J Med Chem; 2008 Nov; 51(22):7216-33. PubMed ID: 18954042
[TBL] [Abstract][Full Text] [Related]
4. Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone: a potent, orally bioavailable human CB1/CB2 dual agonist with antihyperalgesic properties and restricted central nervous system penetration.
Dziadulewicz EK; Bevan SJ; Brain CT; Coote PR; Culshaw AJ; Davis AJ; Edwards LJ; Fisher AJ; Fox AJ; Gentry C; Groarke A; Hart TW; Huber W; James IF; Kesingland A; La Vecchia L; Loong Y; Lyothier I; McNair K; O'Farrell C; Peacock M; Portmann R; Schopfer U; Yaqoob M; Zadrobilek J
J Med Chem; 2007 Aug; 50(16):3851-6. PubMed ID: 17630726
[TBL] [Abstract][Full Text] [Related]
5. Discovery and optimization of a novel series of N-arylamide oxadiazoles as potent, highly selective and orally bioavailable cannabinoid receptor 2 (CB2) agonists.
Cheng Y; Albrecht BK; Brown J; Buchanan JL; Buckner WH; DiMauro EF; Emkey R; Fremeau RT; Harmange JC; Hoffman BJ; Huang L; Huang M; Lee JH; Lin FF; Martin MW; Nguyen HQ; Patel VF; Tomlinson SA; White RD; Xia X; Hitchcock SA
J Med Chem; 2008 Aug; 51(16):5019-34. PubMed ID: 18680277
[TBL] [Abstract][Full Text] [Related]
6. Methylsulfonylpyrazolyl oxadiazoles and thiadiazoles as potent, orally bioavailable cannabinoid-1 receptor antagonists for the treatment of obesity.
Seo HJ; Kim MJ; Song KS; Lee SH; Jung ME; Kim MS; Park HJ; Yoo J; Chang CH; Kim J; Lee J
Future Med Chem; 2009 Aug; 1(5):947-67. PubMed ID: 21426091
[TBL] [Abstract][Full Text] [Related]
7. Low brain penetrant CB1 receptor agonists for the treatment of neuropathic pain.
Adam JM; Clark JK; Davies K; Everett K; Fields R; Francis S; Jeremiah F; Kiyoi T; Maidment M; Morrison A; Ratcliffe P; Prosser A; Schulz J; Wishart G; Baker J; Boyce S; Campbell R; Cottney JE; Deehan M; Martin I
Bioorg Med Chem Lett; 2012 Apr; 22(8):2932-7. PubMed ID: 22421020
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and structure-activity relationships of (indo-3-yl) heterocyclic derivatives as agonists of the CB1 receptor. Discovery of a clinical candidate.
Ratcliffe P; Adam JM; Baker J; Bursi R; Campbell R; Clark JK; Cottney JE; Deehan M; Easson AM; Ecker D; Edwards D; Epemolu O; Evans L; Fields R; Francis S; Harradine P; Jeremiah F; Kiyoi T; McArthur D; Morrison A; Passier P; Pick J; Schnabel PG; Schulz J; Steinbrede H; Walker G; Westwood P; Wishart G; Udo de Haes J
Bioorg Med Chem Lett; 2011 Apr; 21(8):2541-6. PubMed ID: 21411321
[TBL] [Abstract][Full Text] [Related]
9. Diarylimidazolyl oxadiazole and thiadiazole derivatives as cannabinoid CB1 receptor antagonists.
Kim JY; Seo HJ; Lee SH; Jung ME; Ahn K; Kim J; Lee J
Bioorg Med Chem Lett; 2009 Jan; 19(1):142-5. PubMed ID: 19022666
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and cannabinoid activity of 1-substituted-indole-3-oxadiazole derivatives: novel agonists for the CB1 receptor.
Moloney GP; Angus JA; Robertson AD; Stoermer MJ; Robinson M; Wright CE; McRae K; Christopoulos A
Eur J Med Chem; 2008 Mar; 43(3):513-39. PubMed ID: 17582659
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and structure-activity relationship study of conformationally constrained analogs of indole-3-carboxamides as novel CB1 cannabinoid receptor agonists.
Kiyoi T; York M; Francis S; Edwards D; Walker G; Houghton AK; Cottney JE; Baker J; Adam JM
Bioorg Med Chem Lett; 2010 Aug; 20(16):4918-21. PubMed ID: 20634067
[TBL] [Abstract][Full Text] [Related]
12. Discovery of N-[(1S,2S)-3-(4-Chlorophenyl)-2- (3-cyanophenyl)-1-methylpropyl]-2-methyl-2- {[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (MK-0364), a novel, acyclic cannabinoid-1 receptor inverse agonist for the treatment of obesity.
Lin LS; Lanza TJ; Jewell JP; Liu P; Shah SK; Qi H; Tong X; Wang J; Xu SS; Fong TM; Shen CP; Lao J; Xiao JC; Shearman LP; Stribling DS; Rosko K; Strack A; Marsh DJ; Feng Y; Kumar S; Samuel K; Yin W; Van der Ploeg LH; Goulet MT; Hagmann WK
J Med Chem; 2006 Dec; 49(26):7584-7. PubMed ID: 17181138
[TBL] [Abstract][Full Text] [Related]
13. Discovery of 2-(4-((1H-1,2,4-triazol-1-yl)methyl)-5-(4-bromophenyl)-1-(2-chlorophenyl)-1H-pyrazol-3-yl)-5-tert-butyl-1,3,4-thiadiazole (GCC2680) as a potent, selective and orally efficacious cannabinoid-1 receptor antagonist.
Lee J; Seo HJ; Lee SH; Kim J; Jung ME; Lee SH; Song KS; Lee J; Kang SY; Kim MJ; Kim MS; Son EJ; Lee M; Han HK
Bioorg Med Chem; 2010 Sep; 18(17):6377-88. PubMed ID: 20673729
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic optimisation of novel indole-2-carboxamide cannabinoid CB1 antagonists.
Cowley PM; Baker J; Buchanan KI; Carlyle I; Clark JK; Clarkson TR; Deehan M; Edwards D; Kiyoi Y; Martin I; Osbourn D; Walker G; Ward N; Wishart G
Bioorg Med Chem Lett; 2011 Apr; 21(7):2034-9. PubMed ID: 21334892
[TBL] [Abstract][Full Text] [Related]
15. Discovery of S-444823, a potent CB1/CB2 dual agonist as an antipruritic agent.
Odan M; Ishizuka N; Hiramatsu Y; Inagaki M; Hashizume H; Fujii Y; Mitsumori S; Morioka Y; Soga M; Deguchi M; Yasui K; Arimura A
Bioorg Med Chem Lett; 2012 Apr; 22(8):2898-901. PubMed ID: 22421019
[TBL] [Abstract][Full Text] [Related]
16. 2-Arylimino-5,6-dihydro-4H-1,3-thiazines as a new class of cannabinoid receptor agonists. Part 2: orally bioavailable compounds.
Kai H; Morioka Y; Tomida M; Takahashi T; Hattori M; Hanasaki K; Koike K; Chiba H; Shinohara S; Kanemasa T; Iwamoto Y; Takahashi K; Yamaguchi Y; Baba T; Yoshikawa T; Takenaka H
Bioorg Med Chem Lett; 2007 Jul; 17(14):3925-9. PubMed ID: 17531479
[TBL] [Abstract][Full Text] [Related]
17. Discovery of 2-[5-(4-chloro-phenyl)-1-(2,4-dichloro-phenyl)-4-ethyl-1H-pyrazol-3-yl]-1,5,5-trimethyl-1,5-dihydro-imidazol-4-thione (BPR-890) via an active metabolite. A novel, potent and selective cannabinoid-1 receptor inverse agonist with high antiobesity efficacy in DIO mice.
Wu CH; Hung MS; Song JS; Yeh TK; Chou MC; Chu CM; Jan JJ; Hsieh MT; Tseng SL; Chang CP; Hsieh WP; Lin Y; Yeh YN; Chung WL; Kuo CW; Lin CY; Shy HS; Chao YS; Shia KS
J Med Chem; 2009 Jul; 52(14):4496-510. PubMed ID: 19530697
[TBL] [Abstract][Full Text] [Related]
18. Discovery of benzhydrylpiperazine derivatives as CB1 receptor inverse agonists via privileged structure-based approach.
Meng T; Wang J; Peng H; Fang G; Li M; Xiong B; Xie X; Zhang Y; Wang X; Shen J
Eur J Med Chem; 2010 Mar; 45(3):1133-9. PubMed ID: 20047779
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a novel and selective cannabinoid CB1 receptor inverse agonist, Imidazole 24b, in rodents.
Shearman LP; Stribling DS; Camacho RE; Rosko KM; Wang J; Tong S; Feng Y; Marsh DJ; Yu H; Guan X; Spann SK; Macneil DJ; Fong TM; Metzger JM; Goulet MT; Hagmann WK; Plummer CW; Finke PE; Mills SG; Shah SK; Truong Q; Van der Ploeg LH; Macintyre DE; Strack AM
Eur J Pharmacol; 2008 Jan; 579(1-3):215-24. PubMed ID: 18021763
[TBL] [Abstract][Full Text] [Related]
20. Novel pyridine derivatives as potent and selective CB2 cannabinoid receptor agonists.
Chu GH; Saeui CT; Worm K; Weaver DG; Goodman AJ; Broadrup RL; Cassel JA; DeHaven RN; LaBuda CJ; Koblish M; Brogdon B; Smith S; Le Bourdonnec B; Dolle RE
Bioorg Med Chem Lett; 2009 Oct; 19(20):5931-5. PubMed ID: 19736007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
